Angiogenesis pioneer dies

Article

Judah Folkman, MD, the pioneer of angiogenesis research, died on January 15th 2008.

Judah Folkman, MD, the pioneer of angiogenesis research, died on January 15th 2008.

Dr Folkman was the 2006 recipient of the Helen Keller Prize for Vision Research. His 1971 hypothesis, that solid tumours are angiogenesis-dependent, led researchers to the first angiogenic inhibitor for age-related macular degeneration (AMD), laying the groundwork for drugs such as Lucentis and Macugen.

Thanks to Dr Folkman, ten new cancer drugs are on the market and people who might otherwise be blind have been given a lifeline.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.